Roche (RHHBY) News Today $39.71 +0.44 (+1.12%) As of 05/20/2025 03:59 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartDividendHeadlinesInsider TradesOwnershipShort InterestBuy This Stock RHHBY Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Genentech's Columvi label expansion gets negative vote by FDA committeeMay 20 at 8:22 PM | msn.comGenentech Provides Update on FDA Advisory Committee Meeting on Columvi Combination for People With Relapsed or Refractory Diffuse Large B-cell LymphomaMay 20 at 2:58 PM | businesswire.comRoche provides update on FDA Advisory Committee meeting on Columvi combination for people with relapsed or refractory diffuse large B-cell lymphomaMay 20 at 2:40 PM | globenewswire.comIs TIGIT Still A Valid Target In Lung Cancer Patients? Arcus May Be Next To FailMay 19 at 4:33 AM | seekingalpha.comBerenberg Bank Reaffirms Their Hold Rating on Roche Holding AG (RHHVF)May 18 at 5:18 AM | theglobeandmail.comRoche (OTCMKTS:RHHBY) Shares Unloaded Rep. Bruce WestermanRepresentative Bruce Westerman (R-Arkansas) recently sold shares of Roche Holding AG (OTCMKTS:RHHBY). In a filing disclosed on May 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in Roche stock on April 21st. The trade occurred in the Representative's "FISHER IRA" aMay 16, 2025 | marketbeat.comRFK Jr. aide: GLP-1 weight loss meds will cost the same as in least expensive countriesMay 16, 2025 | msn.comMinot DeBlois Advisors LLC Invests $752,000 in Roche Holding AG (OTCMKTS:RHHBY)Minot DeBlois Advisors LLC bought a new position in Roche Holding AG (OTCMKTS:RHHBY - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 21,554 shares of the company's stock, valued at approximateMay 15, 2025 | marketbeat.comRoche receives FDA approval for the VENTANA MET (SP44) RxDx Assay as the first companion diagnostic to identify non-squamous non-small cell lung cancer patients eligible for treatment with EmrelisMay 14, 2025 | globenewswire.comRoche: APHINITY Trial Shows Significant Improvement Of Overall SurvivalMay 14, 2025 | nasdaq.comRoche warns Trump's drug price order puts US investment at riskMay 14, 2025 | finance.yahoo.comRoche reportedly warns Trump’s executive order can risk its U.S. investmentsMay 14, 2025 | msn.comTrump's drug pricing order threatens Roche's $50 billion US investment plans, company saysMay 14, 2025 | reuters.comTen-Year APHINITY Data Show Genentech’s Perjeta-based Regimen Reduced the Risk of Death by 17% in HER2-Positive Early-Stage Breast CancerMay 13, 2025 | uk.finance.yahoo.comTen-year APHINITY data show Roche’s Perjeta-based regimen reduced the risk of death by 17% in people with HER2-positive early-stage breast cancerMay 13, 2025 | finance.yahoo.comTen-Year APHINITY Data Show Genentech's Perjeta-based Regimen Reduced the Risk of Death by 17% in HER2-Positive Early-Stage Breast CancerMay 13, 2025 | businesswire.comTen-year APHINITY data show Roche's Perjeta-based regimen reduced the risk of death by 17% in people with HER2-positive early-stage breast cancerMay 13, 2025 | globenewswire.comRoche plans $700M North Carolina facilityMay 12, 2025 | msn.comRoche announces $550 million investment to expand its Indianapolis diagnostics manufacturing hubMay 12, 2025 | prnewswire.comRoche and Genentech Announce New North Carolina Manufacturing FacilityMay 12, 2025 | businesswire.comRoche to invest $700 million in new drug manufacturing facility in North CarolinaMay 12, 2025 | reuters.comF. Hoffmann-La Roche Ltd: Roche introduces innovative Elecsys PRO-C3 test to improve precision in evaluating liver fibrosis severityMay 6, 2025 | finanznachrichten.deRoche introduces innovative Elecsys PRO-C3 test to improve precision in evaluating liver fibrosis severityMay 6, 2025 | globenewswire.comAristotle Capital Management LLC Reduces Stock Holdings in Roche Holding AG (OTCMKTS:RHHBY)Aristotle Capital Management LLC reduced its stake in shares of Roche Holding AG (OTCMKTS:RHHBY - Free Report) by 4.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,296,080 shares of the company's stocMay 5, 2025 | marketbeat.comInside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambitMay 2, 2025 | cnbc.comRoche (OTCMKTS:RHHBY) Downgraded by Hsbc Global Res to "Hold"Hsbc Global Res lowered Roche from a "strong-buy" rating to a "hold" rating in a research note on Monday.May 1, 2025 | marketbeat.comBlood-Based Biomarkers (BBB) Market Review 2023-2024 and Growth Opportunities 2025-2035 Featuring Profiles of Key Players - Roche, Sysmex Corporation, MiRXES, Minomic, Creative Diagnostics and MoreApril 30, 2025 | globenewswire.comCHMP recommends EU label update for Roche’s Phesgo to allow administration outside of clinical settingsApril 30, 2025 | finance.yahoo.comCHMP recommends EU label update for Roche's Phesgo to allow administration outside of clinical settingsApril 30, 2025 | globenewswire.comRoche Holding AG (OTCMKTS:RHHBY) Given Consensus Recommendation of "Moderate Buy" by AnalystsRoche Holding AG (OTCMKTS:RHHBY - Get Free Report) has received an average recommendation of "Moderate Buy" from the six research firms that are presently covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a sell recommendation, one has assigned a hold rApril 29, 2025 | marketbeat.com3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S. (RHHBY)See these three top-10 stocks in the pharmaceutical industry that are pledging investment in the United States totalling over $100 billion.April 28, 2025 | marketbeat.comNotable healthcare headlines for the week: Merck, Roche and Bausch Health in focusApril 27, 2025 | msn.comRoche price target lowered to CHF 286 from CHF 312 at Morgan StanleyApril 26, 2025 | markets.businessinsider.comRoche: Key Products Stall, Obesity Pipeline Takes ShapeApril 25, 2025 | seekingalpha.comNew England Journal of Medicine Publishes Phase III Data Showing Single-dose Xofluza Significantly Reduces Influenza Virus TransmissionApril 25, 2025 | businesswire.comNew England Journal of Medicine publishes phase III data showing single-dose Xofluza significantly reduces influenza virus transmissionApril 25, 2025 | globenewswire.comRoche seeking U.S. tariff relief in direct talks with White House, Reuters saysApril 24, 2025 | markets.businessinsider.comRoche Holding AG (RHHBY) Q1 2025 Sales/ Trading Statement Call TranscriptApril 24, 2025 | seekingalpha.comRoche reports Q1 group sales CHF 15.4B vs. CHF 14.4B last yearApril 24, 2025 | markets.businessinsider.comEU pharma majors Sanofi, Roche trade flat after reiterated guidanceApril 24, 2025 | msn.comRoche Holding AG: Mixed Q1’25 Results and Strategic U.S. Investments Justify Hold RatingApril 24, 2025 | tipranks.comRoche seeks US tariff relief in direct talks with Trump administrationApril 24, 2025 | reuters.comRoche Sales Rise, Boosted By Key DrugsApril 24, 2025 | wsj.comRoche says Q1 sales up 7%, confirms guidanceApril 24, 2025 | reuters.comRoche Announces Investments Of $50 Bln In The U.S. Over Next Five YearsApril 23, 2025 | nasdaq.comRoche to invest $50B in pharmaceuticals, diagnostics in the U.S. over 5 yearsApril 23, 2025 | markets.businessinsider.comRoche receives CE Mark for its Chest Pain Triage algorithm to enhance detection of Acute Coronary Syndrome (ACS)April 23, 2025 | globenewswire.comRoche to Invest $50 Billion in Pharma, Diagnostics in USApril 22, 2025 | bloomberg.comRoche says it will invest $50 billion in the U.S. as tariff fears hit pharmaApril 22, 2025 | finance.yahoo.comSwiss Pharma Giant Roche To Invest $50B in US Amid Tariff ThreatApril 22, 2025 | investopedia.com Get Roche News Delivered to You Automatically Sign up to receive the latest news and ratings for RHHBY and its competitors with MarketBeat's FREE daily newsletter. Email Address RHHBY Media Mentions By Week RHHBY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RHHBY News Sentiment▼-0.120.65▲Average Medical News Sentiment RHHBY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RHHBY Articles This Week▼138▲RHHBY Articles Average Week Get Roche News Delivered to You Automatically Sign up to receive the latest news and ratings for RHHBY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies China Construction Bank News Airbus News EssilorLuxottica Société anonyme News Iberdrola News Nintendo News BNP Paribas News Atlas Copco News Vinci News Compass Group News Japan Tobacco News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:RHHBY) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roche Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Roche With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RHHBY Stock Free RHHBY Stock Alerts